More on Intuitive Surgical (ISRG): Q2 misses across the board despite an 8% Y/Y increase in total sales. Instruments and accessories revenue increased 18% to $ 265M from $224M in Q212. Its da Vinci surgical procedures grew approximately 18% Y/Y, driven primarily by growth in general surgery, U.S. gynecology and international urology procedures, which were partially offset by a decline in U.S. prostatectomy procedures. Systems revenue declined 6% to $216M however, on fewer sales of the da Vinci surgical system. Shares -6.7% AH.